Myanmar vs United Arab Emirates: Substance use disorder deaths
Myanmar
59.21 deaths
in 2021
United Arab Emirates
49.5 deaths
in 2021
Myanmar rank
84th
United Arab Emirates rank
86th
Substance use disorder deaths over time
- Myanmar
- United Arab Emirates
How they compare
Myanmar currently reports 59.21 deaths against 49.5 deaths in United Arab Emirates, a difference of 9.71 deaths.
That makes Myanmar's figure about 1.2 times United Arab Emirates's.
The two have swapped places 2 times across 22 shared years of data; in 2000 it was Myanmar ahead.
Myanmar ranks 84th and United Arab Emirates ranks 86th of 194 countries.
Across the 3 decades both report, Myanmar averaged higher in 2 and United Arab Emirates in 1.
Head to head by decade
| Decade | Myanmar | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.8 deaths | 21.53 deaths | 28.27 deaths | Myanmar |
| 2010s | 53.3 deaths | 53.52 deaths | 0.219 deaths | United Arab Emirates |
| 2020s | 58.99 deaths | 57.71 deaths | 1.28 deaths | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher substance use disorder deaths, Myanmar or United Arab Emirates?
- Myanmar, at 59.21 deaths against 49.5 deaths in United Arab Emirates as of 2021.
- What is the difference in substance use disorder deaths between Myanmar and United Arab Emirates?
- 9.71 deaths, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and United Arab Emirates?
- 22 years are reported by both, from 2000 to 2021.
- How do Myanmar and United Arab Emirates rank globally for substance use disorder deaths?
- Myanmar ranks 84th and United Arab Emirates ranks 86th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Substance use disorder deaths. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from drug use disorders in both sexes.